|
| |
PositronWe at Positron are focused on bringing our customers the best PET images. We pride ourselves on our ability to interact with our customers on a personal level and be responsive to their needs. At Positron, we stay focused on our customers so that they can stay focused on their patients.
The functional imaging our PET scanners provide make possible the early detection and treatment of cardiac disease, cancer, Alzheimer's disease, and more. Positron scanners are being used in hospitals and diagnostic clinics across the country and worldwide. We do more than just develop PET technology. From site planning to installation, to maintenance, we partner with our customers every step of the way.
| Contact Details: |
| 1304 Langham Creek Dr #300 |
| Houston |
| TX |
| 77084 |
| United States of America |
| Tel: | 281.492.7100 or 800.766.2984 |
| Fax: | 281.492.2661 |
| Email: | contact@positron.com |
| WWW: | www.positron.com/
|
|
Loading...
|
Recent Publications by Positron: |  |
Correlating metabolic activity with cellular proliferation in follicular lymphomas.
PURPOSE: The aim of this study was to correlate metabolic behavior of... | 3rd November, 2009
| Positron Diagnostic Center and Medical Cyclotron, Department of Nuclear
| Mol Imaging Biol. 2009 Sep-Oct;11(5):296-302. Epub 2009 May 9.
DOI Direct Link |
MDMA-evoked changes in the binding of dopamine D(2) receptor ligands in striatum of rats with unilateral serotonin depletion.
We earlier reported an anomalous 50% decrease in [(11)C]N-methylspiperone... | 22nd September, 2009
| Aarhus University Positron Emission Tomography (PET) Center, Aarhus
| Synapse. 2010 Jan;64(1):70-82.
DOI Direct Link |
64Cu-AMD3100--a novel imaging agent for targeting chemokine receptor CXCR4.
CXCR4 is a chemokine receptor which has been shown to be exploited by... | 17th September, 2009
| Positron Emission Tomography Radiochemistry Group, National Institute of
| Bioorg Med Chem. 2009 Feb 15;17(4):1486-93. Epub 2009 Jan 15.
DOI Direct Link |
Radiolabeling of HER2 specific Affibody(R) molecule with F-18.
The presence of human epidermal growth factor type 2 (HER2) on 20-30% of... | 4th September, 2009
| Positron Emission Tomography Radiochemistry Group, NIBIB, Bethesda, MD
| J Fluor Chem. 2008 Sep;129(9):799-805.
DOI Direct Link |
[Strategy for development of imaging biomarkers]
Imaging biomarkers are getting to be more and more important to measure... | 4th September, 2009
| Positron Medical Center, Tokyo Metropolitan Institute for Gerontology, 1-1
| Nihon Shinkei Seishin Yakurigaku Zasshi. 2009 Apr;29(2):67-71.
|
→View more Positron research publications. |
Press Releases on Positron:
|
 |
| Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 |
23rd November, 2009 |
Reportlinker |
NEW YORK, Nov. 23 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.
The Future of the Diagnostic Imaging Market to 2015
http://www
|
| Reportlinker Adds Imaging Agents - A Worldwide Market Review |
20th November, 2009 |
Reportlinker |
NEW YORK, Nov. 20 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.
Imaging Agents - A Worldwide Market Review
http://www.reportlinker.com
|
| Perceptive Informatics Expands Nuclear Imaging Capabilities for Cardiology Trials |
17th November, 2009 |
PAREXEL International Corporation |
BOSTON, Nov. 17 /PRNewswire-FirstCall/ -- Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (Nasdaq: PRXL), today announced that it
|
| U.S. Department of Defense Awards $1.2 Million to Study the Use of Vigabatrin to Reduce the Addictive Liability of Opiates While Still Effectively Managing Pain |
10th November, 2009 |
Catalyst Pharmaceutical Partners |
CORAL GABLES, Fla., Nov. 10 /PRNewswire-FirstCall/ -- Catalyst Pharmaceutical Partners, Inc. (NasdaqCM: CPRX) today reported that a team of neuroscientists at The Feinstein Institute for Medical
|
| High-Resolution Breast PET Improves Breast Cancer Detection |
29th October, 2009 |
Naviscan, Inc. |
-- Combination of PEM and breast MRI dramatically increased number of
suspicious lesions found.
An NIH-sponsored, multi-year study of hundreds of women diagnosed with breast cancer
|
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 330 times since April 2007, the link to the organisation's website has been followed 57 times Recent Search Terms used to find this page: 64Cu-AMD3100 | . Search for more companies in Houston Search for more companies in TX This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Positron |
